Orthotopic Model of Ovarian Cancer

Area of Science:

• Oncology
• Cancer Biology
• Preclinical Models

Background:

• Epithelial ovarian cancer (EOC) remains a leading cause of cancer death in women, with limited survival improvements despite current treatments.
• Metastatic disease is common at diagnosis, highlighting the need for better therapeutic strategies and predictive models.
• Targeting the tumor microenvironment, particularly angiogenesis, is a key focus for novel ovarian cancer treatments.

Purpose of the Study:

• To describe and validate an orthotopic mouse model for studying epithelial ovarian cancer.
• To assess the utility of this model for investigating tumor-stroma interactions, angiogenesis, and metastasis.
• To evaluate the model's potential for personalized medicine, therapeutic response prediction, and biomarker discovery.

Main Methods:

• Establishment of an orthotopic epithelial ovarian cancer model by implanting tumor cells under the ovarian bursa of mice.
• Characterization of the tumor microenvironment at the implant site to mimic human disease conditions.
• Utilizing the model to study tumor dissemination, metastasis, and interactions with the tumor stroma.

Main Results:

• The orthotopic model successfully recreates key aspects of the ovarian cancer microenvironment, including angiogenesis.
• The model facilitates the study of tumor-stroma interactions and the metastatic process characteristic of EOC.
• Despite being labor-intensive, the model provides a valuable platform for preclinical research.

Conclusions:

• The described orthotopic ovarian cancer model is a valuable tool for preclinical research, offering insights into tumor biology and metastasis.
• This model can aid in the assessment of novel therapeutic interventions and the discovery of predictive biomarkers for ovarian cancer.
• Further research utilizing this model can contribute to the development of more effective and personalized treatments for epithelial ovarian cancer.